HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Legionellosis in heart transplant recipients.

AbstractWe report on 20 cases of Legionnaires' Disease (LD) in heart transplant recipients during a two-year study. The overall frequency in this setting amounts thus to 17% (20/115). In contrast, the frequency of legionellosis in postoperative cardiac patients without immunosuppression was only 4.7% (4/84). Legionellosis was diagnosed by culture and/or antibody detection in ten (20) as well as by the detection of urinary antigens in all 20 patients. Only nine (20) patients developed pneumonia, whereas five patients presented with nodular infiltrates. The remaining six patients had moderate fever with no signs of lung infection. In contrast to the majority of patients with other underlying diseases, antigen shedding lasted for long periods in most transplant patients. In high risk patients the application of conventional diagnostic methods together with regular urinary antigen testings (i.e. twice a week) may be advantageous for the early diagnosis of Legionella infection.
AuthorsI Horbach, F J Fehrenbach (Affiliation: Robert Koch-Institut des Bundesgesundheitsamtes, Abteilung Mikrobiologie, Berlin, Germany.)
JournalInfection (Infection) 1990 Nov-Dec Vol. 18 Issue 6 Pg. 361-3 ISSN: 0300-8126 [Print] GERMANY
PMID2076909 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Bacterial (blood)
  • Antigens, Bacterial (urine)
  • Child
  • Cross Infection (etiology)
  • Female
  • Heart Transplantation
  • Humans
  • Immunosuppression
  • Legionella (immunology, isolation & purification)
  • Legionnaires' Disease (etiology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD